Christopher F. Wyatt - 10 Feb 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
10 Feb 2026
Net transactions value
-$2,539,120
Form type
4
Filing time
12 Feb 2026, 18:55:42 UTC
Previous filing
09 Feb 2026

Sponsored

Quoteable Key Fact

"Christopher F. Wyatt filed Form 4 for HCA Healthcare, Inc. (HCA) on 12 Feb 2026."

Quick Takeaways

  • This page summarizes Christopher F. Wyatt's Form 4 filing for HCA Healthcare, Inc. (HCA).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 12 Feb 2026, 18:55.

What Changed

  • Previous filing in this sequence was filed on 09 Feb 2026.
  • Current net transaction value: -$2,539,120.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wyatt Christopher F. SVP & Controller ONE PARK PLAZA, NASHVILLE /s/ Kevin A. Ball, Attorney-in-Fact 12 Feb 2026 0001673365

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +3,350 +7.3% $0.000000 49,413 10 Feb 2026 Direct F1
transaction HCA Common Stock Tax liability $519,120 -1,034 -2.1% $502.05 48,379 10 Feb 2026 Direct
transaction HCA Common Stock Sale $2,020,000 -4,000 -8.3% $505.00 44,379 11 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 30, 2023, the reporting person was granted 1,675 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.